Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications (Q46781887)
Jump to navigation
Jump to search
scientific article published on 5 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications |
scientific article published on 5 June 2012 |
Statements
1 reference
2 references
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications (English)
1 reference
Timothy J Sullivan
1 reference
Daniel J Dairaghi
1 reference
Antoni Krasinski
1 reference
Zhenhua Miao
1 reference
Yu Wang
1 reference
Bin N Zhao
1 reference
Trageen Baumgart
1 reference
Rob Berahovich
1 reference
Linda S Ertl
1 reference
Andrew Pennell
1 reference
Lisa Seitz
1 reference
Shichang Miao
1 reference
Solomon Ungashe
1 reference
Zheng Wei
1 reference
Dan Johnson
1 reference
Landin Boring
1 reference
Chia-Lin Tsou
1 reference
Israel F Charo
1 reference
Pirow Bekker
1 reference
Thomas J Schall
1 reference
Juan C Jaen
1 reference
5 June 2012
1 reference
390-394
1 reference
Identifiers
1 reference
1 reference